{"article_title": "Health care M&A activity continues to soar in 2015", "article_keywords": ["ma", "target", "continues", "cvs", "topic", "trends", "future", "health", "activity", "2015", "soar", "technology", "h2c", "care"], "article_url": "http://www.healthcareglobal.com/financeinsurance/1978/Health-care-M&A-activity-continues-to-soar-in-2015", "article_text": "Health care M&A activity continues to soar in 2015\n\nCVS Health and Target announced on Monday, June 15, that they have a made a deal for CVS to acquire Target\u2019s pharmacy and clinic businesses for $1.9 billion.\n\nAccording to CNN Money, CVS is rebranding the 1,660 pharmacies that Target operates within its stores in 47 states as well as over 80 clinics as MinuteClinic.\n\nWith plans to have 1,500 clinics by 2017, CVS\u2019 deal with Target will allow the company to expand to into new markets such as Seattle, Denver, Salt Lake City, and Portland.\n\nRELATED TOPIC: The 3 most expensive pharmaceutical mergers and acquisitions\n\nIn light of this event, the strategic advisory and investment banking firm Hammond Hanlon Camp LLC (H2C) released the Merger and Acquisition Trends in Healthcare Services report.\n\nAccording to the report, health care mergers and acquisitions reached an all-time record-high value of $388 billion in 2014, which was over $136 billion higher than 2013 levels.\n\nAmong the industry\u2019s service sectors, long-term care and hospitals were leaders in terms of number of transactions and value over the past two years. Continued impact of the Affordable Care Act (\u201cACA\u201d), cost pressures, and access to capital and patient sources were key drivers of hospital merger and acquisition activity.\n\n\u201cMergers and acquisitions remain a key avenue by which many organizations are responding to trends and pursuing growth,\u201d said Michael Hammond, H2C Principal, in an issued press release. \u201cFurthermore, creative partnerships are becoming a vehicle in regional markets that have reached saturated consolidation and concentration.\u201d\n\nRELATED TOPIC: Why pharma companies should invest in Brazil's medical market (and how)\n\nThe outlook for health care M&A activity in 2015 and beyond remains strong, according to H2C, with the impacts of reimbursement changes, price transparency, technology costs, competitive pressures of ACOs/ health exchanges, and need for efficiencies continuing to fuel transactions.\n\nIncreased investment in the health care industry is likely to be seen among private equity and venture capital firms, especially within technology and specialty sectors that can be aggregated for future sale. Those companies that demonstrate capabilities that improve quality, patient satisfaction, cost efficiency, and utilization of \u201cbig data\u201d to drive performance will be in high demand.\n\nRELATED TOPIC: Is this the best alternative to health care M&A?\n\n\u201cThe rising use of technology and \u2018big data\u2019 in all aspects of delivering care will have a transformative effect on health care cost, quality, and convenience factors, influencing future M&A trends,\u201d said Bill Hanlon, H2C Principal.\n\nTo learn what else H2C has to say about the future of health care M&A activity, visit them online.\n\nLet's connect!\n\nRead the latest edition of Healthcare Global magazine!", "article_metadata": {"keywords": "M&A", "og": {"image": "http://www.healthcareglobal.com/public/uploads/large/large_CVS1.jpg", "description": "CVS Health and Target have announced that they have a made a deal for CVS to acquire Target\u2019s pharmacy and clinic businesses for nearly $2 billion.", "title": "Health care M&A activity continues to soar in 2015"}, "description": "CVS Health and Target have announced that they have a made a deal for CVS to acquire Target\u2019s pharmacy and clinic businesses for nearly $2 billion."}, "article_summary": "To learn what else H2C has to say about the future of health care M&A activity, visit them online.\nHealth care M&A activity continues to soar in 2015CVS Health and Target announced on Monday, June 15, that they have a made a deal for CVS to acquire Target\u2019s pharmacy and clinic businesses for $1.9 billion.\nRELATED TOPIC: Is this the best alternative to health care M&A?\nAccording to the report, health care mergers and acquisitions reached an all-time record-high value of $388 billion in 2014, which was over $136 billion higher than 2013 levels.\n\u201cThe rising use of technology and \u2018big data\u2019 in all aspects of delivering care will have a transformative effect on health care cost, quality, and convenience factors, influencing future M&A trends,\u201d said Bill Hanlon, H2C Principal."}